Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics
Source abstract
Abstract
Nanoparticles (NPs) modified by cell membranes represent an emerging biomimetic platform that can mimic the innate biological functions resulting from the various cell membranes in biological systems. researchers focus on constructing the cell membrane camouflaged NPs using a wide variety of cells, such as red blood cell membranes (RBC), macrophages and cancer cells. Cell membrane camouflaged NPs (CMNPs) inherit the composition of cell membranes, including specific receptors, antigens, proteins, for target delivering to the tumor, escaping immune from clearance, and prolonging the blood circulation time, etc. Combining cell membrane-derived biological functions and the NP cores acted cargo carriers to encapsulate the imaging agents, CMNPs are widely developed to apply in tumor imaging techniques, including computed tomography (CT), magnetic resonance imaging (MRI), fluorescence imaging (FL) and photoacoustic imaging (PA). Herein, in this review, we systematically summarize the superior functions of various CMNPs in tumor imaging, especially highlighting the advanced applications in different imaging techniques, which is to provide the theoretical supports for the development of precise guided imaging and tumor treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The ever-increasing importance of cancer as a leading cause of premature death worldwide10.1002/cncr.33587 ↗
2. Cell membrane-camouflaged nanocarriers for cancer diagnostic and therapeutic10.3389/fphar.2020.00024 ↗
3. Synthesis and optimization of MoS2@Fe3O4-ICG/Pt(IV) nanoflowers for MR/IR/PA bioimaging and combined PTT/PDT/chemotherapy triggered by 808 nm laser10.1002/advs.201600540 ↗
4. A Gd-doped polydopamine (PDA)-based theranostic nanoplatform as a strong MR/PA dual-modal imaging agent for PTT/PDT synergistic therapy10.1039/D0TB02725A ↗
5. Construction of smart nanotheranostic platform Bi-Ag@PVP: multimodal CT/PA imaging-guided PDT/PTT for cancer therapy10.1021/acsomega.1c00225 ↗
6. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging10.2147/IJN.S138108 ↗
7. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications10.1016/j.coph.2014.08.002 ↗
8. Ultrasound-Triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imaging10.1021/am301301f ↗
9. Self-Assembled gold nanoclusters for bright fluorescence imaging and enhanced drug delivery-ESI10.1021/acsnano.5b07596 ↗
10. Near-infrared fluorophores for biomedical imaging10.1038/s41551-016-0010 ↗
11. In vivo photoacoustic imaging of livers using biodegradable hyaluronic acid-conjugated silica nanoparticles10.1002/adfm.201800941 ↗
12. Biocompatibility of engineered nanoparticles for drug delivery10.1016/j.jconrel.2012.12.013 ↗
13. In vivo tumor-targeted dual-modality PET/optical imaging with a yolk/shell-structured silica nanosystem10.1007/s40820-018-0216-2 ↗
14. Nanoparticles for detection and diagnosis10.1016/j.addr.2009.11.004 ↗
15. Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point10.1007/s11051-014-2527-7 ↗
16. Nanoparticle-mediated drug delivery and gene therapy10.1021/bp060348j ↗
17. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles10.1016/j.jconrel.2019.03.021 ↗
18. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery10.1016/j.biomaterials.2017.09.020 ↗
19. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: so near and yet so far10.1016/j.addr.2018.06.012 ↗
20. A nanoparticle's pathway into tumours10.1038/s41563-020-0669-9 ↗
21. Molecular modulation of a molybdenum–selenium cluster by sulfur substitution to enhance the hydrogen evolution reaction10.1021/acs.inorgchem.9b02099 ↗
22. Active transcytosis and new opportunities for cancer nanomedicine10.1038/s41563-020-0672-1 ↗
23. Targeting macrophages: therapeutic approaches in cancer, Nature reviews10.1038/nrd.2018.169 ↗
24. Ferritin nanocarrier traverses the blood brain barrier and Kills glioma10.1021/acsnano.7b06969 ↗
25. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
26. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment10.1016/j.apsb.2017.11.009 ↗
27. Cancer cell membrane–biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy10.1021/acsnano.6b04695 ↗
28. Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer10.1039/C5NR02470F ↗
29. Nanoparticle-detained toxins for safe and effective vaccination10.1038/nnano.2013.254 ↗
30. Cell membrane-derived nanomaterials for biomedical applications10.1016/j.biomaterials.2017.02.041 ↗
31. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
32. Red blood cell membrane-enveloped O2 self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy10.7150/thno.37930 ↗
33. Platelet membrane biomimetic bufalin-loaded hollow MnO2 nanoparticles for MRI-guided chemo-chemodynamic combined therapy of cancer10.1016/j.cej.2019.122848 ↗
34. Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy10.1021/acsami.6b00853 ↗
35. Erythrocyte-derived vesicles for circulating tumor cell capture and specific tumor imaging10.1039/C9NR01805K ↗
36. Erythrocyte-derived theranostic nanoplatforms for near infrared fluorescence imaging and photodestruction of tumors10.1021/acsami.8b08005 ↗
37. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy10.1021/acsnano.7b00133 ↗
38. An erythrocyte membrane coated mimetic nano-platform for chemo-phototherapy and multimodal imaging10.1039/C9RA05867B ↗
39. Red-blood-cell-membrane-enveloped magnetic nanoclusters as a biomimetic theranostic nanoplatform for bimodal imaging-guided cancer photothermal therapy10.1039/C9TB01829H ↗
40. Facile phase transfer of hydrophobic Fe3O4@Cu2-xS nanoparticles by red blood cell membrane for MRI and phototherapy in the second near-infrared window10.1039/C9TB02766A ↗
41. Ultra-sensitive nanoprobe modified with tumor cell membrane for UCL/MRI/PET multimodality precise imaging of triple-negative breast cancer10.1007/s40820-020-0396-4 ↗
42. Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy10.1016/j.biomaterials.2021.120979 ↗
43. Cancer cell membrane camouflaged nanoprobe for catalytic ratiometric photoacoustic imaging of MicroRNA in living mice10.1002/adma.201807888 ↗
44. Biodegradable biomimic copper/manganese silicate nanospheres for chemodynamic/photodynamic synergistic therapy with simultaneous glutathione depletion and hypoxia relief10.1021/acsnano.8b09387 ↗
45. Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy10.1039/C8BM00343B ↗
46. Melanoma cell membrane biomimetic versatile CuS nanoprobes for homologous targeting photoacoustic imaging and photothermal chemotherapy10.1021/acsami.9b23177 ↗
47. C-C chemokine ligand 2 (CCL2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer10.1021/acsami.8b11645 ↗
48. Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles10.1002/jbm.a.35927 ↗
49. Active-targeting NIR-II phototheranostics in multiple tumor models using platelet-camouflaged nanoprobes10.1021/acsami.0c16872 ↗
50. Biomimetic "nanoplatelets" as a targeted drug delivery platform for breast cancer theranostics10.1021/acsami.0c19259 ↗
51. Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy10.1016/j.actbio.2018.09.017 ↗
52. Harnessing platelets as functional vectors for contrast enhanced ultrasound imaging and fluorescence imaging10.1039/C9RA05118J ↗
53. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases10.7150/thno.29146 ↗
54. siRNA delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy10.1021/acsbiomaterials.8b00858 ↗
55. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells labeled with Mn2+ and Gd3+ Co-doped CuInS2-ZnS nanocrystals for multimodality imaging in a tumor mice model10.1021/acsami.9b19054 ↗
56. Smart bacterial magnetic nanoparticles for tumor-targeting magnetic resonance imaging of HER2-positive breast cancers10.1021/acsami.8b15838 ↗
57. Bacterial biofilm bioinspired persistent luminescence nanoparticles with gut-oriented drug delivery for colorectal cancer imaging and chemotherapy10.1021/acsami.9b12853 ↗
58. Cancer cell macrophage membrane-camouflaged persistent-luminescent nanoparticles for imaging-guided photothermal therapy of colorectal cancer10.1021/acsanm.0c01433 ↗
59. Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy10.1021/acsami.0c13169 ↗
60. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors10.1016/j.biomaterials.2018.11.021 ↗
61. Nanoparticles for cancer targeting: current and future directions10.2174/1567201813666160713121122 ↗
62. Approaches for the inhibition and elimination of microbial biofilms using macromolecular agents10.1039/D0CS00986E ↗
63. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution10.1016/j.jconrel.2011.10.021 ↗
64. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications10.1038/nnano.2008.34 ↗
65. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform10.1073/pnas.1106634108 ↗
66. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy10.1016/j.actbio.2020.01.036 ↗
67. Cell membrane coating technology: a promising strategy for biomedical applications10.1007/s40820-019-0330-9 ↗
68. Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles10.1002/adma.202004853 ↗
69. Genetically programmable fusion cellular vesicles for cancer immunotherapy10.1002/anie.202108342 ↗
70. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic10.1016/j.jconrel.2018.12.019 ↗
71. Platelet-facilitated photothermal therapy of head and neck squamous cell carcinoma10.1002/anie.201709457 ↗
72. A platelet-mimicking theranostic platform for cancer interstitial brachytherapy10.7150/thno.61259 ↗
73. Capturing cytokines with advanced materials: a potential strategy to tackle COVID-19 cytokine storm10.1002/adma.202100012 ↗
74. A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis10.1039/C8TB01398E ↗
75. Restoring the youth of aged red blood cells and extending their lifespan in circulation by remodelling membrane sialic acid10.1111/jcmm.12721 ↗
76. Erratum: corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes10.1038/srep30663 ↗
77. Erythrocyte-membrane-coated prussian blue/manganese dioxide nanoparticles as H2O2-responsive oxygen generators to enhance cancer chemotherapy/photothermal therapy10.1021/acsami.7b17022 ↗
78. Role of CD47 as a marker of self on red blood cells10.1126/science.288.5473.2051 ↗
79. Imaging of CD47 expression in xenograft and allograft tumor models10.2310/7290.2013.00069 ↗
80. Red blood cell membrane bioengineered Zr-89 labelled hollow mesoporous silica nanosphere for overcoming phagocytosis10.1038/s41598-019-43969-y ↗
81. Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic/chemotherapy10.1021/acsnano.7b08219 ↗
82. Photoacoustic-guided surgery with indocyanine green-coated superparamagnetic iron oxide nanoparticle clusters10.1002/smll.201701300 ↗
83. Photoacoustic imaging of human mesenchymal stem cells labeled with prussian blue-poly(L-lysine) nanocomplexes10.1021/acsnano.7b03519 ↗
84. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging10.1002/cmmi.1638 ↗
85. Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells10.1002/anie.201005075 ↗
86. PEGylated mBPEI-rGO nanocomposites facilitate hepotocarcinoma treatment combining photothermal therapy and chemotherapy10.1016/j.scib.2018.06.003 ↗
87. An erythrocyte membrane coated mimetic nano-platform for chemo-phototherapy and multimodal imaging10.1039/C9RA05867B ↗
88. Nanoparticles and the immune system10.1210/en.2009-1082 ↗
89. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers10.1073/pnas.0509009103 ↗
90. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer10.1039/D0BM00029A ↗
91. Biomimic FeS2 nanodrug with hypothermal photothermal effect by clinical approved NIR-Ⅱ light for augmented chemodynamic therapy10.1016/j.cej.2020.125933 ↗
92. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis
93. Does the immune system see tumors as foreign or self?10.1146/annurev.immunol.21.120601.141135 ↗
94. Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging10.1002/adma.201506086 ↗
95. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
96. Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes10.1021/acs.nanolett.6b02786 ↗
97. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
98. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers10.1182/blood.V95.8.2514 ↗
99. Platelets in inflammation and thrombosis10.1161/01.ATV.0000095974.95122.EC ↗
100. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells10.1182/blood-2009-10-247296 ↗